These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 27302309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.
    Kuroda J, Nobusawa S, Nakamura H, Yokoo H, Ueda R, Makino K, Yano S, Kuratsu J.
    Neuropathology; 2016 Apr; 36(2):181-6. PubMed ID: 26375727
    [Abstract] [Full Text] [Related]

  • 4. A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation.
    Funata N, Nobusawa S, Yamada R, Shinoura N.
    Brain Tumor Pathol; 2016 Jan; 33(1):57-62. PubMed ID: 26602910
    [Abstract] [Full Text] [Related]

  • 5. Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation.
    Tanaka S, Nakada M, Nobusawa S, Suzuki SO, Sabit H, Miyashita K, Hayashi Y.
    Brain Tumor Pathol; 2014 Jul; 31(3):172-6. PubMed ID: 24894018
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adult classical glioblastoma with a BRAF V600E mutation.
    Takahashi Y, Akahane T, Sawada T, Ikeda H, Tempaku A, Yamauchi S, Nishihara H, Tanaka S, Nitta K, Ide W, Hashimoto I, Kamada H.
    World J Surg Oncol; 2015 Mar 11; 13():100. PubMed ID: 25885250
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations.
    Murakami C, Yoshida Y, Yamazaki T, Yamazaki A, Nakata S, Hokama Y, Ishiuchi S, Akimoto J, Shishido-Hara Y, Yoshimoto Y, Matsumura N, Nobusawa S, Ikota H, Yokoo H.
    Brain Tumor Pathol; 2019 Jul 11; 36(3):103-111. PubMed ID: 30972500
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunohistochemical and molecular genetic study on epithelioid glioblastoma: Series of seven cases with review of literature.
    Khanna G, Pathak P, Suri V, Sharma MC, Chaturvedi S, Ahuja A, Bhardwaj M, Garg A, Sarkar C, Sharma R.
    Pathol Res Pract; 2018 May 11; 214(5):679-685. PubMed ID: 29615337
    [Abstract] [Full Text] [Related]

  • 12. Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
    Kanemaru Y, Natsumeda M, Okada M, Saito R, Kobayashi D, Eda T, Watanabe J, Saito S, Tsukamoto Y, Oishi M, Saito H, Nagahashi M, Sasaki T, Hashizume R, Aoyama H, Wakai T, Kakita A, Fujii Y.
    Acta Neuropathol Commun; 2019 Jul 25; 7(1):119. PubMed ID: 31345255
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations: A case report.
    Cai JW, Chen XY, Chen JY, Wu ZY, Wu XY, Yu LH, You HH.
    Medicine (Baltimore); 2021 Apr 02; 100(13):e25346. PubMed ID: 33787635
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma.
    Wang J, Liu Z, Cui Y, Liu Y, Fang J, Xu L, He Y, Du J, Su Y, Zou W, Xu Z, Li G.
    J Neurooncol; 2019 Aug 02; 144(1):137-146. PubMed ID: 31214915
    [Abstract] [Full Text] [Related]

  • 18. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
    Sugimoto K, Ideguchi M, Kimura T, Kajiwara K, Imoto H, Sadahiro H, Ishii A, Kawano H, Ikeda E, Suzuki M.
    Brain Tumor Pathol; 2016 Apr 02; 33(2):137-46. PubMed ID: 26667174
    [Abstract] [Full Text] [Related]

  • 19. Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
    Dono A, Vu J, Anapolsky M, Hines G, Takayasu T, Yan Y, Tandon N, Zhu JJ, Bhattacharjee MB, Esquenazi Y, Ballester LY.
    J Neurooncol; 2020 Sep 02; 149(3):463-472. PubMed ID: 33009979
    [Abstract] [Full Text] [Related]

  • 20. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D, Cho YH, Kang SY, Yoon N, Sung CO, Suh YL.
    J Surg Oncol; 2015 Mar 02; 111(3):359-64. PubMed ID: 25346165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.